Joshua S. Prince
Overview
Joshua S. Prince received $568K in total compensation, including $368K in salary, at Vistagen Therapeutics in 2024.
Source: SEC filing on April 15, 2024.
Related executives
We found seven more executives who work or worked at Vistagen Therapeutics.
Shawn Singh
Vistagen Therapeutics
Chief Executive Officer
Reid Adler
Vistagen Therapeutics
General Counsel
Cynthia Anderson
Vistagen Therapeutics
Chief Financial Officer
Jerrold Dotson
Vistagen Therapeutics
Chief Financial Officer
H Snodgrass
Vistagen Therapeutics
Chief Scientific Officer
Mark Smith
Vistagen Therapeutics
Chief Medical Officer
Mark McPartland
Vistagen Therapeutics